首页> 外文期刊>Frontiers in Medicine >TruSeq-Based Gene Expression Analysis of Formalin-Fixed Paraffin-Embedded (FFPE) Cutaneous T-Cell Lymphoma Samples: Subgroup Analysis Results and Elucidation of Biases from FFPE Sample Processing on the TruSeq Platform
【24h】

TruSeq-Based Gene Expression Analysis of Formalin-Fixed Paraffin-Embedded (FFPE) Cutaneous T-Cell Lymphoma Samples: Subgroup Analysis Results and Elucidation of Biases from FFPE Sample Processing on the TruSeq Platform

机译:福尔马林固定石蜡包埋(FFPE)皮肤T细胞淋巴瘤样品的基于TruSeq的基因表达分析:TruSeq平台上FFPE样品处理的亚组分析结果和偏倚的阐明

获取原文
       

摘要

Cutaneous T-cell lymphomas (CTCLs) are a heterogeneous group of malignancies with courses ranging from indolent to potentially lethal. We recently studied in a 157 patient cohort gene expression profiles generated by the TruSeq targeted RNA gene expression sequencing. We observed that the sequencing library quality and depth from formalin-fixed paraffin-embedded (FFPE) skin samples were significantly lower when biopsies were obtained prior to 2009. We also observed that the fresh CTCL samples clustered together, even though they included stage I–IV disease. In this study, we compared TruSeq gene expression patterns in older (≤2008) vs. more recent (≥2009) FFPE samples to determine whether these clustering analyses and earlier described differentially expressed gene findings are robust when analyzed based on the year of biopsy. We also explored biases found in FFPE samples when subjected to the TruSeq analysis of gene expression. Our results showed that ≤2008 and ≥2009 samples clustered equally well to the full data set and, importantly, both analyses produced nearly identical trends and findings. Specifically, both analyses enriched nearly identical DEGs when comparing benign vs. (1) stage I–IV and (2) stage IV (alone) CTCL samples. Results obtained using either ≤2008 or ≥2009 samples were strongly correlated. Furthermore, by using subgroup analyses, we were able to identify additional novel differentially expressed genes (DEGs), which did not reach statistical significance in the prior full data set analysis. Those included CTCL-upregulated BCL11A, SELL, IRF1, SMAD1, CASP1, BIRC5, and MAX and CTCL-downregulated MDM4, SERPINB3, and THBS4 genes. With respect to sample biases, no matter if we performed subgroup analyses or full data set analysis, fresh samples tightly clustered together. While principal component analysis revealed that fresh samples were spatially closer together, indicating some preprocessing batch effect, they remained in the proximity to other normal/benign and FFPE CTCL samples and were not clustering as outliers by themselves. Notably, this did not affect the determination of DEGs when analyzing ≥2009 samples (fresh and FFPE biopsies) vs. ≥2009 FFPE samples alone.
机译:皮肤T细胞淋巴瘤(CTCL)是一组异质性恶性肿瘤,其病程范围从惰性到可能致命。我们最近研究了由TruSeq靶向RNA基因表达测序产生的157个患者队列基因表达谱。我们观察到,在2009年之前进行活检时,福尔马林固定石蜡包埋(FFPE)皮肤样品的测序文库质量和深度显着降低。我们还观察到新鲜的CTCL样品聚集在一起,即使它们包括I期静脉疾病。在这项研究中,我们比较了较旧的(≤2008年)和较新的(≥2009年)FFPE样品中的TruSeq基因表达模式,以确定当根据活检年份进行分析时,这些聚类分析和较早描述的差异表达基因发现是否可靠。我们还研究了在对基因表达进行TruSeq分析时在FFPE样品中发现的偏倚。我们的结果表明,≤2008年和≥2009年的样本均能很好地聚类到整个数据集,而且重要的是,两种分析都产生了几乎相同的趋势和发现。具体而言,当比较良性与(1)I–IV期和(2)IV期(单独)CTCL样品时,两种分析均富集了几乎相同的DEG。使用≤2008或≥2009样本获得的结果高度相关。此外,通过使用亚组分析,我们能够鉴定出其他新的差异表达基因(DEG),这些基因在先前的完整数据集分析中未达到统计学意义。那些包括CTCL上调的BCL11A,SELL,IRF1,SMAD1,CASP1,BIRC5和MAX,以及CTCL下调的MDM4,SERPINB3和THBS4基因。关于样本偏差,无论我们执行亚组分析还是完整数据集分析,新鲜样本都紧密地聚集在一起。主成分分析显示,新鲜样品在空间上更靠近,表明有一些预处理批处理效果,但它们仍与其他正常/良性和FFPE CTCL样品接近,并且自身未聚类为异常值。值得注意的是,与仅对≥2009FFPE样品进行分析相比,这不影响分析≥2009样品(新鲜和FFPE活检)时DEG的确定。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号